BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 17097156)

  • 1. A dual chamber model of female cervical mucosa for the study of HIV transmission and for the evaluation of candidate HIV microbicides.
    Van Herrewege Y; Michiels J; Waeytens A; De Boeck G; Salden E; Heyndrickx L; van den Mooter G; de Béthune MP; Andries K; Lewi P; Praet M; Vanham G
    Antiviral Res; 2007 May; 74(2):111-24. PubMed ID: 17097156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of an in vitro dual-chamber model of the female genital tract as a screening tool for epithelial toxicity.
    Gali Y; Ariën KK; Praet M; Van den Bergh R; Temmerman M; Delezay O; Vanham G
    J Virol Methods; 2010 May; 165(2):186-97. PubMed ID: 20138087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of reverse transcriptase inhibitors in monocyte-derived dendritic cells: a possible in vitro model for postexposure prophylaxis of sexual HIV transmission.
    Van Herrewege Y; Penne L; Vereecken C; Fransen K; van der Groen G; Kestens L; Balzarini J; Vanham G
    AIDS Res Hum Retroviruses; 2002 Oct; 18(15):1091-102. PubMed ID: 12396448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4 mimetic miniproteins: potent anti-HIV compounds with promising activity as microbicides.
    Van Herrewege Y; Morellato L; Descours A; Aerts L; Michiels J; Heyndrickx L; Martin L; Vanham G
    J Antimicrob Chemother; 2008 Apr; 61(4):818-26. PubMed ID: 18270220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro pre- and post-exposure prophylaxis using HIV inhibitors as microbicides against cell-free or cell-associated HIV-1 infection.
    Terrazas-Aranda K; Van Herrewege Y; Lewi PJ; Van Roey J; Vanham G
    Antivir Chem Chemother; 2007; 18(3):141-51. PubMed ID: 17626598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A dual-chamber model of the female genital tract to evaluate epithelial toxicity of candidate anti-HIV microbicides.
    Ariën KK; Vanham G; Gali Y
    Curr Protoc Cell Biol; 2011 Sep; Chapter 26():Unit26.13. PubMed ID: 21898337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DABOs as candidates to prevent mucosal HIV transmission.
    Pani A; Musiu C; Loi AG; Mai A; Loddo R; La Colla P; Marongiu ME
    Antivir Chem Chemother; 2001; 12 Suppl 1():51-9. PubMed ID: 11594689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervical and prostate primary epithelial cells are not productively infected but sequester human immunodeficiency virus type 1.
    Dezzutti CS; Guenthner PC; Cummins JE; Cabrera T; Marshall JH; Dillberger A; Lal RB
    J Infect Dis; 2001 Apr; 183(8):1204-13. PubMed ID: 11262202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human genital epithelial cells capture cell-free human immunodeficiency virus type 1 and transmit the virus to CD4+ Cells: implications for mechanisms of sexual transmission.
    Wu Z; Chen Z; Phillips DM
    J Infect Dis; 2003 Nov; 188(10):1473-82. PubMed ID: 14624372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbohydrate-binding agents efficiently prevent dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN)-directed HIV-1 transmission to T lymphocytes.
    Balzarini J; Van Herrewege Y; Vermeire K; Vanham G; Schols D
    Mol Pharmacol; 2007 Jan; 71(1):3-11. PubMed ID: 17056872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human immunodeficiency virus type 1 (HIV-1) integration: a potential target for microbicides to prevent cell-free or cell-associated HIV-1 infection.
    Terrazas-Aranda K; Van Herrewege Y; Hazuda D; Lewi P; Costi R; Di Santo R; Cara A; Vanham G
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2544-54. PubMed ID: 18474579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-mediated HTLV-I infection of a cervix-derived epithelial cell line.
    Zacharopoulos VR; Phillips DM
    Microb Pathog; 1997 Oct; 23(4):225-33. PubMed ID: 9344783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV endocytosis after dendritic cell to T cell viral transfer leads to productive virus infection.
    Clotet-Codina I; Bosch B; Senserrich J; Fernández-Figueras MT; Peña R; Ballana E; Bofill M; Clotet B; Esté JA
    Antiviral Res; 2009 Jul; 83(1):94-8. PubMed ID: 19501262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-incubation of cell-free HIV-1 group M isolates with non-nucleoside reverse transcriptase inhibitors blocks subsequent viral replication in co-cultures of dendritic cells and T cells.
    Njai HF; Lewi PJ; Janssen CG; Garcia S; Fransen K; Kestens L; Vanham G; Janssen PA
    Antivir Ther; 2005; 10(2):255-62. PubMed ID: 15865220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-type lectin Mermaid inhibits dendritic cell mediated HIV-1 transmission to CD4+ T cells.
    Nabatov AA; de Jong MA; de Witte L; Bulgheresi S; Geijtenbeek TB
    Virology; 2008 Sep; 378(2):323-8. PubMed ID: 18597806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mucosal immune system in the human female reproductive tract: potential insights into the heterosexual transmission of HIV.
    Yeaman GR; White HD; Howell A; Prabhala R; Wira CR
    AIDS Res Hum Retroviruses; 1998 Apr; 14 Suppl 1():S57-62. PubMed ID: 9581885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyanovirin-N potently inhibits human immunodeficiency virus type 1 infection in cellular and cervical explant models.
    Buffa V; Stieh D; Mamhood N; Hu Q; Fletcher P; Shattock RJ
    J Gen Virol; 2009 Jan; 90(Pt 1):234-43. PubMed ID: 19088294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early events in HIV transmission through a human reconstructed vaginal mucosa.
    Bouschbacher M; Bomsel M; Verronèse E; Gofflo S; Ganor Y; Dezutter-Dambuyant C; Valladeau J
    AIDS; 2008 Jul; 22(11):1257-66. PubMed ID: 18580604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbohydrate-binding agents (CBAs) inhibit HIV-1 infection in human primary monocyte-derived macrophages (MDMs) and efficiently prevent MDM-directed viral capture and subsequent transmission to CD4+ T lymphocytes.
    Pollicita M; Schols D; Aquaro S; Peumans WJ; Van Damme EJ; Perno CF; Balzarini J
    Virology; 2008 Jan; 370(2):382-91. PubMed ID: 17928023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inefficient human immunodeficiency virus replication in mobile lymphocytes.
    Sourisseau M; Sol-Foulon N; Porrot F; Blanchet F; Schwartz O
    J Virol; 2007 Jan; 81(2):1000-12. PubMed ID: 17079292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.